{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:10:08Z","timestamp":1756365008244,"version":"3.44.0"},"reference-count":12,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"abstract":"<jats:p>A 46-year-old man with a long-standing history of Crohn\u2019s disease who was treated with multiple therapies over a period of 9\u2005years presented with oral lesions which on biopsy demonstrated peripheral T-cell lymphoma. Initially, the development of T-cell lymphoma was presumed to be secondary to prolonged immunosuppression but it did not respond to withholding immunosuppressive therapy. On treatment with CHOP (cyclophosphamide, hydroxydaunorubicin, oncovin and prednisone) chemotherapy, complete remission was achieved. Although development of malignancies in the immune-suppressed patient with Crohn's disease has been previously described but we present a rare case of T-cell lymphoma in a similar patient, which has not been reported before.<\/jats:p>","DOI":"10.1136\/bcr-2013-200606","type":"journal-article","created":{"date-parts":[[2013,10,10]],"date-time":"2013-10-10T14:58:30Z","timestamp":1381417110000},"page":"bcr2013200606","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Peripheral T-cell lymphoma in a patient with Crohn\u2019s disease"],"prefix":"10.1136","volume":"2013","author":[{"given":"Srilakshmi Sudha","family":"Kollepara","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, DMC Sinai Grace Hospital, Detroit, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Muhsin","family":"Chisti","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hematology and Oncology, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, USA"},{"name":"Department of Hematology and Oncology, Oakland University William Beaumont School of Medicine, Livonia, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seerin Viviane","family":"Shatavi","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, William Beaumont Hospital, Royal Oak, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishmael A","family":"Jaiyesimi","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, William Beaumont Hospital, Royal Oak, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,10,10]]},"reference":[{"key":"2025082723333121000_2013.oct09_3.bcr2013200606.1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/gast.2000.16487","article-title":"Hodgkin's disease risk is increased in patients with ulcerative colitis","volume":"2013","author":"Palli","year":"2000","journal-title":"Gastroenterology"},{"key":"2025082723333121000_2013.oct09_3.bcr2013200606.2","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1053\/gast.2001.28703","article-title":"Inflammatory bowel disease is not associated with an increased risk of lymphoma","volume":"2013","author":"Lewis","year":"2001","journal-title":"Gastroenterology"},{"key":"2025082723333121000_2013.oct09_3.bcr2013200606.3","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/gut.2003.018515","article-title":"Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County","volume":"2013","author":"Ljung","year":"2004","journal-title":"Gut"},{"key":"2025082723333121000_2013.oct09_3.bcr2013200606.4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1586\/eci.10.36","article-title":"Update on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel disease","volume":"2013","author":"Bewtra","year":"2010","journal-title":"Expert Rev Clin Immunol"},{"key":"2025082723333121000_2013.oct09_3.bcr2013200606.5","first-page":"1167e98","article-title":"Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review","volume":"2013","author":"Gutierrez-Dalmau","year":"2007","journal-title":"Drugs"},{"key":"2025082723333121000_2013.oct09_3.bcr2013200606.6","first-page":"2735e42","article-title":"Posttransplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry","volume":"2013","author":"Caillard","year":"2006","journal-title":"Am J Transplant"},{"key":"2025082723333121000_2013.oct09_3.bcr2013200606.7","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10350-006-0848-z","article-title":"The risk of cancer in patients with Crohn's disease","volume":"2013","author":"Von Roon","year":"2007","journal-title":"Dis Colon Rectum"},{"key":"2025082723333121000_2013.oct09_3.bcr2013200606.8","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/gut.2004.049460","article-title":"Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine","volume":"2013","author":"Kandiel","year":"2005","journal-title":"Gut"},{"key":"2025082723333121000_2013.oct09_3.bcr2013200606.9","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.cgh.2009.01.004","article-title":"Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis","volume":"2013","author":"Siegel","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025082723333121000_2013.oct09_3.bcr2013200606.10","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/ajg.2011.479","article-title":"Lymphoma in inflammatory bowel disease and treatment decisions","volume":"2013","author":"Bewtra","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"2025082723333121000_2013.oct09_3.bcr2013200606.11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ajg.2012.334","article-title":"T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-\u03b1) inhibitors: results of the REFURBISH study","volume":"2013","author":"Deepak","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"2025082723333121000_2013.oct09_3.bcr2013200606.12","first-page":"119","article-title":"A case of rapid growing colonic NK\/T cell lymphoma complicated by Crohn's disease","volume":"2013","author":"Zheng","year":"2013","journal-title":"Cancer Res"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2013-200606","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:33:42Z","timestamp":1756362822000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2013-200606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,10]]},"references-count":12,"alternative-id":["10.1136\/bcr-2013-200606"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2013-200606","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2013,10,10]]}}}